Apyx Medical Corporation (APYX)
NASDAQ:APYX
Want to see APYX full AI Analyst Report?
Total Valuation
Apyx Medical has a market cap or net worth of $153.68M. The enterprise value is $126.91M.
Market Cap$153.68M
Enterprise Value$126.91M
Share Statistics
Apyx Medical has 41,873,950 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding41,873,950
Owned by Insiders1.54%
Owned by Institutions7.69%
Financial Efficiency
Apyx Medical’s return on equity (ROE) is -0.77 and return on invested capital (ROIC) is -11.60%.
Return on Equity (ROE)-0.77
Return on Assets (ROA)-0.17
Return on Invested Capital (ROIC)-11.60%
Return on Capital Employed (ROCE)-0.12
Revenue Per Employee240.20K
Profits Per Employee-50.48K
Employee Count220
Asset Turnover0.79
Inventory Turnover3.93
Valuation Ratios
The current PE Ratio of Apyx Medical is ―. Apyx Medical’s PEG ratio is 0.22.
PE Ratio―
PS Ratio2.79
PB Ratio10.15
Price to Fair Value10.15
Price to FCF-16.19
Price to Operating Cash Flow-19.21
PEG Ratio0.22
Income Statement
In the last 12 months, Apyx Medical had revenue of 52.84M and earned -11.21M in profits. Earnings per share was -0.27.
Revenue52.84M
Gross Profit19.03M
Operating Income-6.45M
Pretax Income-10.84M
Net Income-11.21M
EBITDA-5.79M
Earnings Per Share (EPS)-0.27
Cash Flow
In the last 12 months, operating cash flow was -7.87M and capital expenditures -1.12M, giving a free cash flow of -8.99M billion.
Operating Cash Flow-7.87M
Free Cash Flow-8.99M
Free Cash Flow per Share-0.21
Dividends & Yields
Apyx Medical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.01
52-Week Price Change232.13%
50-Day Moving Average3.70
200-Day Moving Average3.15
Relative Strength Index (RSI)58.39
Average Volume (3m)120.72K
Important Dates
Apyx Medical upcoming earnings date is Aug 6, 2026, After Close (Confirmed).
Last Earnings DateMay 7, 2026
Next Earnings DateAug 6, 2026
Ex-Dividend Date―
Financial Position
Apyx Medical as a current ratio of 5.00, with Debt / Equity ratio of 34.09%
Current Ratio5.00
Quick Ratio4.26
Debt to Market Cap0.24
Net Debt to EBITDA-1.31
Interest Coverage Ratio-1.15
Taxes
In the past 12 months, Apyx Medical has paid 270.00K in taxes.
Income Tax270.00K
Effective Tax Rate-0.02
Enterprise Valuation
Apyx Medical EV to EBITDA ratio is -26.80, with an EV/FCF ratio of -17.02.
EV to Sales2.94
EV to EBITDA-26.80
EV to Free Cash Flow-17.02
EV to Operating Cash Flow-19.39
Balance Sheet
Apyx Medical has $31.14M in cash and marketable securities with $4.37M in debt, giving a net cash position of $26.76M billion.
Cash & Marketable Securities$31.14M
Total Debt$4.37M
Net Cash$26.76M
Net Cash Per Share$0.64
Tangible Book Value Per Share$0.35
Margins
Gross margin is 38.14%, with operating margin of -12.20%, and net profit margin of -21.22%.
Gross Margin38.14%
Operating Margin-12.20%
Pretax Margin-20.50%
Net Profit Margin-21.22%
EBITDA Margin-10.96%
EBIT Margin-12.20%
Analyst Forecast
The average price target for Apyx Medical is $6.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$6.00
Price Target Upside91.69% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast18.22%
EPS Growth Forecast59.43%